Dr. Yale Jen Analyzes Key Drivers of Biotech Pricing Power in NAVLIN Daily

 In a recent interview with NAVLIN Daily, Laidlaw’s Senior Managing Director and Healthcare Equity Analyst Dr. Yale Jen shares his perspective on innovation and the factors driving enduring pricing power across the biotech industry.

Read the interview here